| Combretastatin A4 | IC50 | 1200.0 [1] |
| Combretastatin A4 | Ki | 3.0 [1], 120.0 [2] |
| Colchicine | IC50 | 2900.0 [1] |
| Colchicine | Ki | 2400.0 [1] |
| Podofilox | IC50 | 1700.0 [1] |
| Nocodazole | IC50 | 760.0 [1], 810.0 [2], 1640.0 [3], 1980.0 [4] |
| Vinblastine | IC50 | 70.0 [1], 300.0 [2], 2100.0 [3] |
| Thiocolchicine | IC50 | 650.0 [1], 2100.0 [2] |
| Abt-751 | IC50 | 2400.0 [1], 2880.0 [2] |
| Abt-751 | Ki | 1510.0 [1] |
| (z)-2-Methoxy-5-(3,4,5-trimethoxystyryl)aniline | IC50 | 1200.0 [1], 3981.07 [2], 6500.0 [3] |
| 1-(4-Methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene | IC50 | 1500.0 [1], 2187.76 [2], 2200.0 [3] |
| Methyl 5-chloro-3-(3,4,5-trimethoxyphenyl)sulfanyl-1H-indole-2-carboxylate | IC50 | 2500.0 [1] |
| Vinorelbine | IC50 | 700.0 [1], 2000.0 [2] |
| Dolastatin 10 | IC50 | 0.5 [1], 1200.0 [2] |
| 5,3'-Dihydroxy-3,6,7,8,4'-pentamethoxyflavone | IC50 | 830.0 [1] |
| (Z)-3,5,4'-Trimethoxystilbene | IC50 | 3500.0 [1], 3801.89 [2] |
| Methyl 5-methoxy-3-(3,4,5-trimethoxyphenyl)sulfanyl-1H-indole-2-carboxylate | IC50 | 2000.0 [1] |
| N-(2,3-Dihydro-1,4-benzodioxin-6-yl)-5-[2-(pyridin-3-ylmethylamino)pyridin-3-yl]-1,3,4-oxadiazol-2-amine | IC50 | 30.0 [1], 700.0 [2] |
| N-(1,3-Benzodioxol-5-yl)-5-[2-(pyridin-4-ylmethylamino)pyridin-3-yl]-1,3,4-oxadiazol-2-amine | IC50 | 30.0 [1], 1000.0 [2] |
| 2-Methoxy-5-(3,4,5-trimethoxy-phenoxy)-phenol | IC50 | 16218.1 [1], 16300.0 [2] |
| N-(2,3-Dihydro-1,4-benzodioxin-6-yl)-5-[2-(pyridin-2-ylmethylamino)pyridin-3-yl]-1,3,4-oxadiazol-2-amine | IC50 | 190.0 [1], 1900.0 [2] |
| N-(1,3-Benzodioxol-5-yl)-5-[2-(pyridin-2-ylmethylamino)pyridin-3-yl]-1,3,4-oxadiazol-2-amine | IC50 | 30.0 [1], 1700.0 [2] |
| Boronic acid, trans-6 | IC50 | 1500.0 [1], 22000.0 [2] |
| [7-(3-Hydroxyprop-1-ynyl)-6-methoxy-2H-indazol-3-yl]-(3,4,5-trimethoxyphenyl)methanone | IC50 | 46.0 [1], 240.0 [2] |
| N-(2,3-Dihydro-1,4-benzodioxin-6-yl)-5-[3-(pyridin-2-ylmethylamino)thiophen-2-yl]-1,3,4-oxadiazol-2-amine | IC50 | 75.0 [1], 4400.0 [2] |
| N-(2,3-Dihydro-1,4-benzodioxin-6-yl)-5-[2-(pyridin-2-ylmethylamino)phenyl]-1,3-oxazol-2-amine | IC50 | 10.0 [1], 1400.0 [2] |
| N-(2,3-Dihydro-1,4-benzodioxin-6-yl)-5-[2-(pyridin-2-ylmethylamino)phenyl]-1,3,4-oxadiazol-2-amine | IC50 | 390.0 [1], 1200.0 [2] |
| N-(2,3-Dihydro-1,4-benzodioxin-6-yl)-5-[2-(oxolan-2-ylmethylamino)pyridin-3-yl]-1,3,4-oxadiazol-2-amine | IC50 | 390.0 [1], 1700.0 [2] |
| 6-[(Z)-3-(3,4,5-Trimethoxyphenyl)prop-2-enyl]-1-benzothiophen-4-ol | IC50 | 1160.0 [1], 24600.0 [2] |
| 6-[(Z)-3-(3,4,5-Trimethoxyphenyl)prop-2-enyl]-1-benzofuran-4-ol | IC50 | 2500.0 [1], 10300.0 [2] |
| (E)-1-(6-Methoxy-1,3-benzoxathiol-5-yl)-3-(4-methoxyphenyl)prop-2-en-1-one | IC50 | 489.0 [1], 5800.0 [2] |
| (E)-1-(5-Methoxy-1,3-benzoxathiol-6-yl)-3-(4-methoxyphenyl)prop-2-en-1-one | IC50 | 108.0 [1], 4150.0 [2] |
| (5-Ethylpyrido[4,3-b]indol-8-yl)-(4-methylsulfonylphenyl)methanone | IC50 | 4300.0 [1] |
| Vincristine | IC50 | 500.0 [1] |
| Vincaleukoblastine | IC50 | 150.0 [1] |
| Vinblastine sulfate | IC50 | 130.0 [1] |
| Docetaxel | IC50 | 500.0 [1] |
| Epothilone B | IC50 | 3.5 [1] |
| Combretastatin | IC50 | 5000.0 [1] |
| Eupatilin | IC50 | 40000.0 [1] |
| Deoxypodophyllotoxin | IC50 | 2400.0 [1] |
| 3,3',4',5,6,7,8-Heptamethoxyflavone | IC50 | 40000.0 [1] |
| Santin | IC50 | 5700.0 [1] |
| Centaureidin | IC50 | 2000.0 [1] |
| Pectolinarigenin | IC50 | 40000.0 [1] |
| Ternatin | IC50 | 40000.0 [1] |
| Dolastatin 15 | IC50 | 23000.0 [1] |
| 5-Hydroxy-3,6,7,8,3',4'-hexamethoxyflavone | IC50 | 40000.0 [1] |
| 2-Phenylquinolin-4-ol | IC50 | 7300.0 [1] |
| Ayanin | IC50 | 40000.0 [1] |
| Curacin A | IC50 | 720.0 [1] |
| Curacin B | IC50 | 820.0 [1] |
| Curacin C | IC50 | 2300.0 [1] |
| Phenstatin | IC50 | 3400.0 [1] |
| Demethylnobiletin | IC50 | 40000.0 [1] |
| Erianin | IC50 | 3311.31 [1] |
| Ustiloxin A | IC50 | 1100.0 [1] |
| 4'-Demethyldeoxypodophyllotoxin | IC50 | 2000.0 [1] |
| Vinfosiltine | IC50 | 800.0 [1] |
| Methyl (13S,15S,17S)-13-[(1R,9R,10S,11R,12R,19R)-10-[[(1R)-1-diethoxyphosphoryl-2-methylpropyl]carbamoyl]-12-ethyl-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-ethyl-17-hydroxy-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-13-carboxylate | IC50 | 400.0 [1] |
| (3S,10R,13E,16S)-10-[(4-Methoxyphenyl)methyl]-3-(2-methylpropyl)-16-[(1S)-1-[(2R,3R)-3-phenyloxiran-2-yl]ethyl]-1,4-dioxa-8,11-diazacyclohexadec-13-ene-2,5,9,12-tetrone | IC50 | 15000.0 [1] |
| (E)-3-(3-Hydroxy-4-methoxyphenyl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one | IC50 | 10000.0 [1] |
| Gardenin A | IC50 | 40000.0 [1] |
| 3-(3-Hydroxy-4-methoxyphenyl)-8h-thieno[2,3-b]pyrrolizin-8-one | IC50 | 2900.0 [1] |
| Kokusaginine | IC50 | 820.0 [1] |
| Ustiloxin D | IC50 | 1500.0 [1] |
| 2-(3,4,5-Trimethoxyphenyl)-4H-chromen-4-one | IC50 | 40000.0 [1] |
| Quercetin 3,4'-dimethyl ether | IC50 | 3000.0 [1] |
| 2-Amino-7-(dimethylamino)-4-(7-methoxy-1,3-benzodioxol-5-yl)-4H-chromene-3-carbonitrile | IC50 | 400.0 [1] |
| 2-Amino-4-(3-bromo-4,5-dimethoxyphenyl)-7-(dimethylamino)-4H-chromene-3-carbonitrile | IC50 | 8000.0 [1] |
| 3-(3-Hydroxy-4-methoxyphenyl)-2-methyl-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one | IC50 | 1800.0 [1] |
| 2-Styrylquinazolin-4(3H)-one | IC50 | 11000.0 [1] |
| N-Deacetylthiocolchicine | IC50 | 1300.0 [1] |
| (1-Methyl-1H-indol-5-yl)(3,4,5-trimethoxyphenyl)methanone | IC50 | 1100.0 [1] |
| Methanone, (4-methoxyphenyl)(3,4,5-trimethoxyphenyl)- | IC50 | 7413.1 [1] |
| 2-(3-Methoxyphenyl)-6-pyrrolidin-1-yl-1H-quinolin-4-one | IC50 | 440.0 [1] |
| 2-Demethylthiocolchicine | IC50 | 2000.0 [1] |
| Cryptophycin | IC50 | 3700.0 [1] |
| 3-Hydroxy-3',4',5,7-tetramethoxyflavone | IC50 | 40000.0 [1] |
| 5,4'-Dihydroxy-3,6,7,8,3'-pentamethoxyflavone | IC50 | 40000.0 [1] |
| 3-Demethylthiocolchicine | IC50 | 2000.0 [1] |
| 2-(4-Fluorophenyl)quinazolin-4-ol | IC50 | 40000000.0 [1] |
| Vintrypol | IC50 | 200.0 [1] |
| 1,2,3-Trimethoxy-5-[2-(4-methoxyphenyl)ethyl]benzene | IC50 | 7943.28 [1] |
| Methyl 3-(phenylthio)-1H-indole-2-carboxylate | IC50 | 8300.0 [1] |
| 2-(4-Methoxyphenyl)-3-(3,4,5-trimethoxybenzoyl)-6-methoxybenzo[b]thiophene | IC50 | 40000.0 [1] |
| (3,4,5-Trimethoxyphenyl)[2-(3-hydroxy-4-methoxyphenyl)-6-methoxybenzo[b]thiophene-3-yl] ketone | IC50 | 3500.0 [1] |
| 3-Hydroxy-2-(2,4,6-trimethoxyphenyl)chromen-4-one | IC50 | 31000.0 [1] |
| 2-(3,4-Dimethoxyphenyl)-3-hydroxy-7-methoxy-4H-chromen-4-one | IC50 | 40000.0 [1] |
| 1H-Indole-2-carboxylic acid, 3-(phenylsulfonyl)-, ethyl ester | IC50 | 4400.0 [1] |
| [2-(3-Hydroxy-4-methoxyphenyl)-6-methoxy-1H-indol-3-yl]-(3,4,5-trimethoxyphenyl)methanone | IC50 | 1600.0 [1] |
| (3Z)-6-(4-Hydroxy-3-methoxyphenyl)-3-(1H-pyrrol-2-ylmethylene)-1,3-dihydro-2H-indol-2-one | IC50 | 130.0 [1] |
| 2-(3-Methoxyphenyl)quinazolin-4(3H)-one | IC50 | 8600000.0 [1] |
| (4R)-4-[(1Z,5E,7E,11R)-11-Methoxytetradeca-1,5,7,13-tetraenyl]-2-[(1R,2S)-2-methylcyclopropyl]-4,5-dihydro-1,3-thiazole | IC50 | 4800.0 [1] |
| 3-(4-Hydroxy-3-methoxyphenyl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one | IC50 | 2600.0 [1] |
| 1H-Indole-2-carboxylic acid, 3-(phenylthio)-, ethyl ester | IC50 | 4400.0 [1] |
| 2-Methoxy-5-[(alphaS,betaS)-alpha,beta-dihydroxy-3,4,5-trimethoxyphenethyl]phenol | IC50 | 22000.0 [1] |
| Ustiloxin F | IC50 | 8200.0 [1] |
| (Z)-1,2,3-Trimethoxy-5-(4-methoxy-3-nitrostyryl)benzene | IC50 | 1800.0 [1] |